CDK1 and neoplasm: Kinase–substrate enrichment analysis (KSEA) further illustrated the activation of CDK1/2, which played a central role in cell cycle regulation, in the high-TMB group (Fig. S2D), hinting at abnormal up-regulation of tumor proliferation and therapeutic potential of CDK inhibitors.